# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013681
Filing Date
2024-04-29
Accepted
2024-04-29 16:06:55
Documents
9
Period of Report
2024-06-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | crvo20240425_def14a.htm | DEF 14A | 563329
2 |  | a01.jpg | GRAPHIC | 13074
3 |  | crvo01.jpg | GRAPHIC | 260782
4 |  | crvo02.jpg | GRAPHIC | 185553
5 |  | crvo20240425_def14aimg004.jpg | GRAPHIC | 5741
6 |  | crvo20240425_def14aimg005.jpg | GRAPHIC | 17268
7 |  | crvo20240425_def14aimg006.jpg | GRAPHIC | 17387
8 |  | logosm.jpg | GRAPHIC | 10403
9 |  | logosmr.jpg | GRAPHIC | 8046
| Complete submission text file | 0001437749-24-013681.txt |  | 1279166

Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 24890656
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)